2005
DOI: 10.1016/j.jss.2005.01.017
|View full text |Cite
|
Sign up to set email alerts
|

Isoproterenol Reduces Ischemia-Reperfusion Lung Injury Despite β-Blockade1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2006
2006
2017
2017

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 35 publications
0
4
0
Order By: Relevance
“…Although PC loss is one of the important features of DR and is presumed to be related to the initial onset of DR lesions, such as such as microaneurysm, vascular leakage, and proliferative neovascularization (43, 44), little is known about the direct causal relationship between PC loss and vascular leakage in DR. PC detachment from cerebral blood vessels is also known to impair barrier function (45), and PC loss in cardiac coronary vessels increases vascular permeability (46, 47). In addition, a growing body of evidence has shown that β‐agonists significantly reduce endothelial permeability in lung caused by multiple stimuli, such as inflammation (48), thrombin (49), and ischemia–reperfusion injury (50). These studies showed the effect of β‐AR stimulation on EC integrity, but the effect of β‐AR stimulation on PC survival and vascular leakage remained unknown.…”
Section: Discussionmentioning
confidence: 99%
“…Although PC loss is one of the important features of DR and is presumed to be related to the initial onset of DR lesions, such as such as microaneurysm, vascular leakage, and proliferative neovascularization (43, 44), little is known about the direct causal relationship between PC loss and vascular leakage in DR. PC detachment from cerebral blood vessels is also known to impair barrier function (45), and PC loss in cardiac coronary vessels increases vascular permeability (46, 47). In addition, a growing body of evidence has shown that β‐agonists significantly reduce endothelial permeability in lung caused by multiple stimuli, such as inflammation (48), thrombin (49), and ischemia–reperfusion injury (50). These studies showed the effect of β‐AR stimulation on EC integrity, but the effect of β‐AR stimulation on PC survival and vascular leakage remained unknown.…”
Section: Discussionmentioning
confidence: 99%
“…Almost all of the studies on ischemia-reperfusion injury in NHBDs are focused on the changes occurring in the reperfusion phase while the inflammatory and cellular changes during the warm ischemic period remain poorly understood. [21][22][23][24] Geudens et al [7] showed that the cellular changes already occur during warm ischemia, and these were correlated with the length of the ischemic period in the mouse model. In this study, it was demonstrated that the number of macrophages and lymphocytes in bronchoalveolar lavage increases with longer warm ischemic intervals, and a significant rise occurs between 60 and 90 minutes of ischemia.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, new evidences identified interesting properties of this drug. For instance, isoproterenol attenuates ischemiareperfusion injury even in the presence of beta-blockade (24).…”
Section: Discussionmentioning
confidence: 99%